IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$499.30 USD
+10.06 (2.06%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $499.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Brokerage Reports
0 items in cart
IDEXX Laboratories, Inc. [IDXX]
Reports for Purchase
Showing records 401 - 417 ( 417 total )
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
In Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Today''s Morning Exchange.
Provider: KAUFMAN BROTHERS
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Today''s Morning Exchange
Provider: KAUFMAN BROTHERS
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
In Today''s Morning Exchange.
Provider: KAUFMAN BROTHERS
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
$0.06 EPS Beat; Raised Guidance; Introduced New Product Launch.
Provider: KAUFMAN BROTHERS
Analyst: BROCK D
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Today''s Morning Exchange.
Provider: KAUFMAN BROTHERS
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
In Today''s Morning Exchange.
Provider: KAUFMAN BROTHERS
Company: IDEXX Laboratories, Inc.
Industry: Medical - Instruments
Initiating Coverage with a BUY Rating and $70 Price Target.
Provider: KAUFMAN BROTHERS
Analyst: BROCK D